CCR8 is a new therapeutic target in cutaneous T-cell lymphomas.
Giustiniani J, Dobos G, Moins-Teisserenc H, Eustaquio T, Battistella M, Ortonne N, Ram-Wolff C, Bouaziz JD, Marie-Cardine A, Mourah S, Bagot M, Kupper TS, Clark RA, Bensussan A, de Masson A.
Giustiniani J, et al.
Blood Adv. 2022 Jun 14;6(11):3507-3512. doi: 10.1182/bloodadvances.2021006512.
Blood Adv. 2022.
PMID: 35201316
Free PMC article.
No abstract available.